Why Novo Nordisk and Eli Lilly Are Suing Each Other - and What It Means for You
In July 2026, the two biggest names in weight-loss medicine went to court against each other. Novo Nordisk, maker of Wegovy and Ozempic, sued Eli Lilly, maker of Zepbound and Mounjaro, over how Lilly advertises its drugs. Novo filed the suit on July 21 and, on July 24, asked a federal judge for a preliminary injunction to halt Lilly's ads right away. The core complaint: Novo says Lilly's TV and social-media campaigns compare Lilly's highest-dose drugs against older, lower doses of Wegovy and Ozempic, while barely mentioning Novo's newer, higher-dose versions.
Why does an advertising fight matter to patients? Because most people learn about these medicines from ads, not from medical journals. Doctors can see the full clinical evidence; a shopper watching a 30-second commercial cannot. If an ad quietly compares a strong dose of one drug against a weak dose of another, it can leave the impression that one medicine is far better than it really is. That is the heart of Novo's case, and Lilly rejects it, saying its ads rely on proper head-to-head clinical trials.
What should you take from this? Do not choose a weight-loss medicine based on an ad. The main GLP-1 options - Wegovy, Ozempic, Zepbound, Mounjaro, and the newer pills Foundayo and the Wegovy pill - differ in how they are taken, their doses, their side effects, and how much weight people lose. The most reliable comparison is a well-designed head-to-head trial, but the choice that fits you depends on your health, your routine, and your insurance. Your doctor or pharmacist is the right person to sort that out with you.
The bigger picture is that competition in this field is intense - and that is mostly good news for patients. More approved drugs, more pharmacy options, and pricing programs like the Medicare GLP-1 Bridge mean more people can get treatment. A courtroom fight over ads is a sign of how high the stakes have become. If you are considering one of these medicines, talk to your doctor about which one suits you. This is general information, not medical advice.